ArticleEuropean journal of nuclear medicine and molecular imaging2026
First-in-human tandem Terbium-161 and Actinium-225 PSMA radioligand therapy in metastatic castration-resistant prostate cancer.
Omer Aras et al.PubMed ↗Publisher ↗
No numbers read from the abstract.